TAX ENHANCEMENT USING ADVANCED BIOTECHNOLOGY

Discover how Testing for Humanity is deploying 700,000 free advanced cancer-risk tests to underserved communities nationwide, supported by federal agencies and backed by top-tier legal and accounting teams. Learn how Chamber members may be able to leverage significant 2025 tax advantages—up to 4.5X deductions—while contributing to a project that reduces CMS waste and fraud and accelerates early cancer detection for those who need it most.
Attendees will also hear how investors may participate in the equity of Testing for Humanity, a rising biotech company positioned to become a premier national genomic data bank, with more than 2 million samples expected next year.
This event is designed for leaders who want to maximize tax efficiency, support high-impact innovation, and be part of a landmark public health initiative. Don’t miss this rare opportunity to learn, network, and make a measurable difference.